Published Papers

This section contains citations for scientific papers and articles that feature information about ISBT 128.

Cellular Therapy

Traceability

Medical Devices

Ocular

Tissue

Blood

Reproductive

Newsletters

Graphic Publications

• Neller J, K, Ashford P, van Veen C, Humpe A. Global Registration Identifier for Donors (GRID) of Hematopoietic Stem Cells: Road to Automation and Safety. Transfus Med Hemother 2017;44:407-413.

• Slaper-Cortenbach, Ineke; ISBT 128 coding and labeling for cellular therapy products . Cell and Tissue Banking (2010). http://www.springerlink.com/content/65n1372431n0r711/fulltext.pdf 

• Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Terminology and labeling of cellular products: 1. Standards. Bone marrow transplantation 2007;40(11):1075-83.

• Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Terminology and labeling of cellular products 2: Implementation plan. Bone marrow transplantation 2007;40(11):1085-90.

• Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Standards for the terminology and labeling of cellular therapy products.Transfusion 2007;47(7):1319-27.

  http://onlinelibrary.wiley.com/doi/10.1111/j.1537-2995.2007.01389.x/pdf

   

  You must be a registered member with AABB to access this publication.

• Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; ISBT 128 implementation plan for cellular therapy products. Transfusion 2007;47(7):1312-8.

  http://onlinelibrary.wiley.com/doi/10.1111/j.1537-2995.2007.01390.x/pdf

   

  You must be a registered member with AABB to access this publication.

• Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; ISBT 128 implementation plan for cellular therapy products. Journal of clinical apheresis 2007;22(5):258-64.

• Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Standards for the terminology and labeling of cellular therapy products. Journal of clinical apheresis 2007;22(5):249-57.

[Top ↑]

• Ashford P, Delgado M. ISBT 128 Standard for Coding Medical Products of Human Origin. Transfus Med Hemother 2017;44:386-390.

[Top ↑]

• Conway, Karen. The Human Side of UDI. Healthcare Purchasing News. Healthcare Purchasing News, July 2016.

• Mahajan R, Kuehnert MJ. How can we improve tracking of transplanted tissue in the United States? Cell Tissue Bank. 2014 Sep;15(3):287-9. doi: 10.1007/s10561-013-9408-7. Epub 2013 Nov 27.

• DePaolo JS, Barbeau JM. Enhanced Tracking of Tissue for Transplantation. JAMA. 2013 Feb 6;309(5):443-4. doi: 10.1001/jama.2012.145043.

• Brubaker SA, Wilson D. Coding and Traceability: cells and tissues in North America. Cell Tissue Bank. 2010 Nov;11(4):379-89. doi: 10.1007/s10561-010-9219-z. Epub 2010 Aug 26.

• Strong DM, Shinozaki N. Coding and Traceability for Cells, Tissues and Organs for Transplantation. Cell Tissue Bank. 2010 Nov;11(4):305-23. doi: 10.1007/s10561-010-9179-3. Epub 2010 May 13.]

[Top ↑]

• W. John Armitage, PhD; Paul Ashford, MSc; Barbara Crow; Patricia Dahl; Pat Distler, MS; Jennifer DeMatteo, MCM, CIC; Usha Gopinathan, PhD; Mark Mannis, MD; S. Louise Moffatt, BSc; Christina Parsons; Diego Ponzin, MD; Donald Tan, MD. Implementation of Standardized Terminology and ISBT 128 Product Codes for Ocular Tissue. International Journal of Eye Banking vol. 2 no. 1, March 2014. doi:10.7706/ijeb.v2i1.64.
  Implementation of Standardized Terminology and ISBT 128 Product Codes for Ocular Tissue
   
• Armitage, W. John; Ashford, Paul; Crow, Barbara; Dahl, Patricia; DeMatteo, Jennifer; Distler, Pat; Gopinathan, Usha; Madden, Peter W.; Mannis, Mark J.; Moffatt, S. Louise; Ponzin, Diego; Tan, Donald. Standard Terminology and Labeling of Ocular Tissue for Transplantation.Cornea32(6):725-728, June 2013. doi: 10.1097/ICO.0b013e3182873405.
  Standard Terminology and Labeling of Ocular Tissue for Transplantation

[Top ↑]

• Mahajan R, Kuehnert MJ. How can we improve tracking of transplanted tissue in the United States? Cell Tissue Bank. 2014 Sep;15(3):287-9. doi: 10.1007/s10561-013-9408-7. Epub 2013 Nov 27.

• DePaolo JS, Barbeau JM. Enhanced Tracking of Tissue for Transplantation. JAMA. 2013 Feb 6;309(5):443-4. doi: 10.1001/jama.2012.145043.

• Strong DM, Shinozaki N. Coding and Traceability for Cells, Tissues and Organs for Transplantation. Cell Tissue Bank. 2010 Nov;11(4):305-23. doi: 10.1007/s10561-010-9179-3. Epub 2010 May 13.

• Brubaker SA, Wilson D. Coding and Traceability: cells and tissues in North America. Cell Tissue Bank. 2010 Nov;11(4):379-89. doi: 10.1007/s10561-010-9219-z. Epub 2010 Aug 26.

• Distler, P. ISBT 128: A global information standard.  Cell and Tissue Banking (2010). Published online 21 July 2010. 

• Ashford, P. Traceability. Cell and Tissue Banking (2010). Published online 14 July 2010.

• From the Sixty Third World Health Assembly WHA 63.22 Human Organ and Tissue Transplantation

• Fehily, D., Ashford, P., Poniatowski, S. Traceability of Human Tissues for Transplantation – the development and implementation of a coding system using ISBT 128. Organs and Tissues (2004) (2) 83-88.

[Top ↑]

• EBA Board adopts Position Paper on the labelling, coding and identification of blood, blood components, tissues and cells
  At the Board Meeting in Valletta, Malta, the EBA Board has voted to support the universal use of the ISBT 128 for labelling, coding and identification of blood, blood components, tissues and cells.

EBA Position Paper on Coding and Labeling – PDF (01 Oct 2010)

• Guidelines for the use of RFID technology in transfusion medicine. Vox Sang (2010) 98:1-24. (Special Issue)

• Ashford, P. Gullikson J, Georgsen, J and Distler, P.  Standard terminology for platelet additive solutions.  Vox Sang (2010) 98(4):577-578.

• Ashford P. Fearon M., Bedford R.  Report on the joint IBEPAG/ICCBBA survey on import/export and blood component labeling. Vox Sang (2010) 98, 85–86. 

• Distler, PB. ISBT 128 An internationally standardized means to label cellular therapy products. Pharmaceuticals Policy and Law (2007) 9:421-430.

• Ashford, P. ISBT 128: contributing to the safety of transfusion and transplantation. ISBT 128 Science Series (2007) 2:113-116.

• Ashford P.  ISBT 128 – Improving Security by International Standardization. ISBT Science Series (1) 242-245 (2006).

• Butch, SH. and Distler, PB. ISBT 128 blood labeling: introduction and reference laboratory applications. Immunohematology (2006): 22:30-35.

• Munk, Charles et al., ISBT 128: The Implementation Project of the Swiss Red Cross Blood Transfusion Service. ISBT Congress Proceeding, Journal of Blood Banks, and Transfusion Society of Turkey, July (2003).

[Top ↑]

P. Ashford,  K. Rydman  A. Sparks  K. Tilleman  M. Freire; "Standard terminology for reproductive tissue and cell products for use in ART". Human Reproduction Open. Volume 2019, Issue 2, pp. 1-4.

[Top ↑]

• Distler, Pat. Advantages of ISBT 128 Labeling and Standardization. Medical Lab Management (July-August 2013) Vol. 2 No. 4 - Page 6.

• Brubaker, SA. Tissue tracking failures and lessons learned: Hope for the future. GxP Lifeline (2010). Originally published by GxP Lifeline.

• Slaper-Cortenbach, ICM. ICCBBA and ISBT 128 - value for money? Blood and Transplant Matters (Spring 2010). Page 13. 

• Strong, MA. Cells and Tissue Traceability and ISBT 128. GxP Lifeline (2009).

[Top ↑]

• Norwegian Poster - PDF (3 MB)
• Stem Cell Labeling - PPT (6 MB)

[Back to Top ↑]